title: 5-HT4-mediated neuroprotection: a new therapeutic modality on the way?
authors.affiliation: Department of Pathology and Cell Biology, Columbia University, New York, New York mdg4@columbia.edu.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Gershon
mesh_terms: D001572:Benzofurans / Q000494:pharmacology*; D017615:Enteric Nervous System / Q000166:cytology / Q000187:drug effects; D007249:Inflammation / Q000378:metabolism / Q000517:prevention & control; D009474:Neurons / Q000187:drug effects; D018696:Neuroprotective Agents / Q000494:pharmacology; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology; D044422:Receptors, Serotonin, 5-HT4 / Q000378:metabolism*; D058828:Serotonin 5-HT4 Receptor Agonists / Q000494:pharmacology*
chemical_list: D001572:Benzofurans; D018696:Neuroprotective Agents; D058828:Serotonin 5-HT4 Receptor Agonists; C406662:prucalopride; D044422:Receptors, Serotonin, 5-HT4